Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed
Journal of Clinical Oncology · 2024
DOI: 10.1200/jco.23.01314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von Claudia Rossig und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
ZORA (Zurich Open Repository and Archive) provides open and worldwide access to the research and scholarly output of the University of Zurich, Switzerland. A focus is on qualified scientific publications. ZORA is operated by the University Library together with the Central IT of the University of Zurich.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- ACCELERATE, Brussels, Belgium.
- Department of Paediatric and Adolescent Oncology, Institut Gustave Roussy and Paris-Saclay University, Villejuif, France.
- Zoe4Life, Sullens, Switzerland.
- Solving Kids' Cancer UK, London, United Kingdom.
ORCID-Profile: Claudia Rossig, Andrew D Pearson, Gilles Vassal, Nicole Scobie, Nick Bird, Patricia Blanc, H Josef Vormoor, Franco Locatelli, Francesca Del Bufalo, Susana Rives, Elad Jacoby, Adriana Balduzzi, Jean-Pierre Bourquin, André Baruchel
Zitieren
APA
Rossig, C., Pearson, A. D., Vassal, G., Scobie, N., Bird, N., Blanc, P., Vormoor, H. J., Calkoen, F. G., Locatelli, F., Del Bufalo, F., Rives, S., Jacoby, E., Balduzzi, A., Bourquin, J. P., & Baruchel, A. (2024). Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed. Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.01314
Vancouver
Rossig C, Pearson AD, Vassal G, Scobie N, Bird N, Blanc P, et al. Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed. Journal of Clinical Oncology. 2024. doi:10.1200/jco.23.01314
BibTeX
@article{Rossig2024,
author = {Rossig, Claudia and Pearson, Andrew D and Vassal, Gilles and Scobie, Nicole and Bird, Nick and Blanc, Patricia and Vormoor, H Josef and Calkoen, Friso G and Locatelli, Franco and Del Bufalo, Francesca and Rives, Susana and Jacoby, Elad and Balduzzi, Adriana and Bourquin, Jean-Pierre and Baruchel, André},
title = {Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed},
journal = {Journal of Clinical Oncology},
year = {2024},
doi = {10.1200/jco.23.01314}
}
EUVIMED